![]() | This article is rated B-class on Wikipedia's
content assessment scale. It is of interest to the following WikiProjects: | ||||||||||||||||||||||||||||||
|
![]() | Ideal sources for Wikipedia's health content are defined in the guideline
Wikipedia:Identifying reliable sources (medicine) and are typically
review articles. Here are links to possibly useful sources of information about Flecainide.
|
Hello Lucky. I recently worked a few hours on this article, and was going to put even more hours on it. Yesterday night I checked it and it was deleted by you due to "copyvio". My intention was to create the most complete article about Flecainide. Before this, when I personally went out on the web looking for information, I always found bits and pieces all over, but was not satisfied with any one article about it. My intention was to MERGE all public domain information until a nice, detailed, structured and very complete article was created.
Although I did use several public domain sources, the amount of editing, merging, thinking, re-structuring (of the article), makes me feel like it was my own work. Maybe it was not yet complete, but I intended to keep working on it. If you look on the web, you will not find any article as complete as this one. Also, being a drug which has specific properties, indications & contraindications, it is natural that you will find many similarities in all articles.
So: I still want to see an article containing all possible information about this drug. I cannot write from memory because I am not the manufacturer of the drug or the researcher that invented or discovered it. All I have are public domain sources. What do you suggest I do?
This article contains bits and pieces from numerous sources. I encourage whoever read this to summarize, restructure, modify, add and do whatever necesary to "wikify" this article. I still want it as complete as possible, but would like to clear any redundancy and make it structurally clearer. Any help is welcome!
Some sections of this document are copied word for word from the product monograph which can be found at: http://products3.3m.com/catalog/us/en001/government/innovative_solutions/node_GSYQ1KL450be/root_GS3RBW6QFVgv/vroot_31S2JJ7584ge/gvel_KJ6SPF8WRSgl/theme_us_innovativesolutions_3_0/command_AbcPageHandler/output_html
specifically the clinical indications section. 85% of the clinical indications section is from this work. If the rest of this article is similarly derived then I don't know if much of this article can be salvaged. I'm not experienced enough, nor do I want to bother, to check through this entire article for copyright violations. Could the original author please clarify these concerns. Matt 16:40, 27 Jul 2004 (UTC)
You have listed the following pages as your sources: None of these are public domain, could you please specify which public domain sources you've used.
To Matt: OK. Will do. These days I am super busy and I will try to work on it in the following 30 days. Any help from your part will be more than welcome. One question: Is the product information/instructions (whatever comes with the physical product) something considered Public Domain or would you consider it copyrighted? -- AAAAA 04:09, 28 Jul 2004 (UTC)
I'm listing this page on WP:RFC to encourage third parties who are familiar with wikipedia policies and procedures to become involved and hopefully resolve this dilemma.
I discovered this page when I noticed that a drug page was on the list of the largest pages in wikipedia (it was ~60k at the time). With a google search I quickly found that the page's contents were copy and pasted from various copyrighted sources (see "Clarification needed on copyright" above).
Since the content of the page was almost entirely contributed by one user, I also brought up the issue on his talk page. (see user_talk:AAAAA and user_talk:MattKingston for the discussion that resulted from this.) AAAAA conceded that the content was c&p from copyrighted sites.
I reverted the page to the copyright vio notice (AAAAA had previously been warned, but given the benefit of doubt).
Since that time, AAAAA has been slowly copying the copyvio material back into the article. Virtually no effort has been made to reword the content in his own words, or even correct formatting errors. The article contains a lot of inane facts (such as packaging details) and doesn't even barely resemble an encyclopedia article.
I'm hesitant to simply re-revert the article since that doesn't seem to lead anywhere, I'm posting on WP:RFC in hopes that third party intervention will lead to some agreement between AAAAA and myself. Matt 06:45, 30 Aug 2004 (UTC)
I took out the part that you consider rewritten without effort. I was hoping that after some time you would forget about watching this page, but I guess I was wrong. I give up. -- AAAAA 11:30, 30 Aug 2004 (UTC)
I think there is some confusion about what the term public domain refers to, AAAAA seems to use the term to mean things that are publicly accessible, this is not the legal definition of the term. In order for something to be public domain the creator must release it into the public domain, or it must be very old and its copyright elapsed. While a lot of information about Flecainide may be available on the internet and accessible to the public, it is not "public domain" and cannot be added to Wikipedia without permission. On another topic, generally it is better to resolve conflicts directly by attaining consensus than it is to hope someone will stop watching. The issues Matt raises are very real, I don't see the benefit of ignoring them. [[User:Cohesion|cohesion ☎]] 19:29, 13 Sep 2004 (UTC)
I have another question: How "original" does something have to be to NOT be considered a copy? If someone takes the information contained in 10 or 20 different articles, deletes may parts, arranges other parts, adds comments and/or explanations, categorizes, combines from several sentences, etc, etc, is the end result considered a copy? It you copy verbatim 10,000 characters, it is definitely considered a copy. If you copy and paste a picture, it is definitely a copy. But if you "use" one character (an "A" for example), it cannot be considered a copy. If you "use" one word it still cannot be considered a copy. If you use 2 words? How many words would make something a copy? Where do you draw the line? When can you say something has been "re-written" or when is it not "re-written" enough? -- AAAAA 03:03, 14 Sep 2004 (UTC)
Hi AAAAA, I was wondering what to do with flecainide. At the moment, it requires some attention. Do you have any plans, or can I have a go? JFW | T@lk 22:08, 16 Oct 2004 (UTC)
Rhobite and Matt, please watch out what you revert. I was halfway working on this, and expect to finish in 2-3 days. And leave AAAAA alone for the moment. JFW | T@lk 16:59, 21 Oct 2004 (UTC)
That was not nice, reverting to some old horrible version while I'd been working on it to remove copyvio material. Anyway, I have restored the previous version and removed all text that was copyvioed, to satisfy everybody. I will ask User:Ksheka to review this and add his expertise. JFW | T@lk 17:24, 18 Nov 2004 (UTC)
The statements:
"For the treatment of life-threatening ventricular arrhythmias (ie: ventricular tachycardia), a starting dose of 100 mg twice a day may be appropriate."
and
"Results of a medical study known as the Cardiac Arrhythmia Suppression Trial (CAST) demonstrated that patients with structural heart disease (such as a history of MI (heart attack), or left ventricular dysfunction) and also patients with ventricular arrhythmias, should not take this drug."
seem to contradict eachother. I take this drug for ventricular tachycardia - am I risking my life or not? —Preceding unsigned comment added by 66.29.174.66 ( talk) 09:19, 3 October 2007 (UTC)
I have some concerns that the following phrase from the opening paragraphs of this article is oversimple for such a technical article.
"Flecainide works by regulating the flow of sodium in the heart, thus slowing nerve impulses"
Now there are Sodium channels involved in nerve conduction, very similar or identical to those found in the His-Purkinje system and myocardial cells. But to say that Flecainide slows nerve impulses (it may well for all I know!) seems misleading as the depolarisation of myocardial cells and the propogation of electrical activity across the heart does not involve nerve impulses.
Accordingly, I have changed this phrase.
Feel free to comment guys and gals. In the spirit of Wikiquette, feel free to change it back, or indeed to better and please leave me a comment to explain. —Preceding unsigned comment added by 163.160.252.16 ( talk) 22:44, 29 January 2008 (UTC) -- I have another question: is the drug Flecainide (title) or Flecainide acetate (beginning of description)? Presumably, the flecainide acetate is simple the acetic acid salt. It is not the same product. I recommend removing the word 'acetate' from the beginning of the description. —Preceding unsigned comment added by Mccooeye ( talk • contribs) 14:26, 11 August 2010 (UTC)
A book written for laymen about the discovery, testing and use of tambocor:
DEADLY MEDICINE: WHY TENS OF THOUSANDS OF HEART PATIENTS DIED IN AMERICA'S WORST DRUG DISASTER, Thomas Moore, Simon and Schuster, 1995, ISBN-10: 0684804174, ISBN-13: 978-0684804170
Brief summary: antiarrythmics were overprescribed and, TO THE SURPRISE OF THE EXPERTS, resulted in "excess deaths" over what you would expect without treatment. AdderUser ( talk) 20:30, 8 December 2011 (UTC)
The comment(s) below were originally left at Talk:Flecainide/Comments, and are posted here for posterity. Following several discussions in past years, these subpages are now deprecated. The comments may be irrelevant or outdated; if so, please feel free to remove this section.
Comment(s) | Press [show] to view → |
---|---|
The following suggestions were generated by a semi-automatic
javascript program, and might not be applicable for the article in question.
|
Last edited at 22:26, 2 June 2007 (UTC). Substituted at 15:15, 29 April 2016 (UTC)
This article refers to cloud on the safety of flecainide created by the CAST trial, as follows:
"Results of a medical study known as the Cardiac Arrhythmia Suppression Trial (CAST) demonstrated that patients with structural heart disease (such as a history of MI (heart attack), or left ventricular dysfunction) and also patients with ventricular arrhythmias, should not take this drug. The results were so significant that the trial was stopped early and preliminary results were published."
Flecainide use has indeed been reduced by this finding. However, later metanalysis has found this concern created by the CASET trial t be substantially overstated, partly because specific subgroups within the CAST trial were the ones most adversely affected. As one example, see Debra S. Echt, MD, & Jeremy N. Ruskin, MD, "Use of Flecainide for the Treatment of Atrial Fibrillation," Am J Cardiology 2020;125:1123−1133.
This newer analysis should be reflected in the article, which otherwise discourages the use of flecainide in many patients who would appear to benefit from it. 216.166.175.72 ( talk) 21:53, 4 September 2023 (UTC)